On August 29, Abdulla Azizov, First Deputy Minister of Health of Uzbekistan and Director of the Pharmaceutical Industry Development Agency, led a delegation to visit Unicornshell's Beijing Business Center. Accompanying members included Jakhongir Yakubov, Director of the Investment Department, and Azamat Abdinabiev, Assistant to the Director. The visit aimed to deepen exchanges and cooperation between China and Uzbekistan in the pharmaceutical sector, jointly exploring opportunities for industrial upgrading and technology implementation under the Belt and Road framework.

During the visit, the delegation focused on understanding Unicornshell's process innovations in plant-based hollow capsules, achievements in modernizing traditional Chinese medicine projects, and international market expansion efforts. They also engaged in in-depth discussions regarding pharmaceutical industry upgrade needs in Central Asia. Both parties explored cooperation pathways for promoting the export of plant-based pharmaceutical excipient technologies and localizing production under the Belt and Road Initiative, opening new avenues for Sino-Uzbek pharmaceutical industry collaboration. The Uzbek delegation expressed high recognition of Unicornshell's capabilities in green pharmaceuticals, innovative materials, and smart manufacturing, and looks forward to further deepening cooperation in the future.

Headquartered in Shanghai, Unicornshell specializes in the R&D, production, and sales of plant-based pharmaceutical excipients and innovative traditional Chinese medicine formulations, committed to becoming a leader in the intelligent manufacturing industry of plant capsules. The company has successfully launched hydroxypropyl methylcellulose capsules (first generation) and hydroxypropyl starch capsules (second generation), widely applied in pharmaceuticals and nutritional supplements to provide green, safe excipient solutions for the global pharmaceutical industry. Leveraging an industrial cluster model, Unicornshell integrates smart manufacturing with new materials to empower traditional pharmaceutical upgrades through new productive forces, advancing green pharmaceuticals and the modernization of traditional Chinese medicine.

Looking ahead, Unicornshell will leverage foreign trade channels as a breakthrough point, focusing on expanding into Central Asia, Southeast Asia, and European markets. Through technology export and industrial synergy, it will continuously advance its global footprint, striving to become the industry leader in plant-based capsules. This exchange not only deepened strategic mutual trust between China and Uzbekistan but also set a new benchmark for international cooperation and technological promotion in plant-based pharmaceutical excipients. It contributes “Chinese momentum” to the high-quality development of the pharmaceutical industry in countries along the Belt and Road.